Status: Recruiting
Phase III Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
This multicentre phase III clinical trial will target adults and adolescents of 12 years and older with severe burns to confirm the efficacy and functionality of denovoSkin™ in achieving wound closure and reducing scarring in patients with deep partial and full-thickness burns as compared to split-thickness skin.
Participants needed: 70
Trial details
Phase: Phase 3Age: 12+Biological sex: AllType: InterventionalSponsor: CUTISS AGUpdated: Aug 10, 2026Locations: 19
Eligibility criteria
Patients with deep partial or full-thickness thermal burns of ≥20% total body su... [+2]
Burn wound areas solely located on the head and neck (i.e., test and control are... [+11]